Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Cash & Current Investments (2020 - 2021)

Historic Cash & Current Investments for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to $393.7 million.

  • Design Therapeutics' Cash & Current Investments changed N/A to $393.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $393.7 million, marking a year-over-year change of. This contributed to the annual value of $36.1 million for FY2020, which is N/A changed from last year.
  • Latest data reveals that Design Therapeutics reported Cash & Current Investments of $393.7 million as of Q3 2021.
  • Over the past 5 years, Design Therapeutics' Cash & Current Investments peaked at $411.3 million during Q1 2021, and registered a low of $36.1 million during Q4 2020.